FDA Drug Recalls

3 recalls · Class III, newest first

Jul 9, 2025 Class III · Low risk

Sub-Potent Drug: Subpotent assay results during stability testing.

Completed Wrong potency / content Imprimis NJOF, LLC NDC 71384-733-05 D-0536-2025

Feb 24, 2025 Class III · Low risk

Presence of foreign tablets/capsules

Completed Particulate / foreign matter Kowa Pharmaceuticals America NDC 66869-404-90 D-0258-2025

Jan 16, 2025 Class III · Low risk

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

Completed Failed specification Appco Pharma LLC NDC 43598-943-90 D-0208-2025

Recalls by year